These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11228051)

  • 1. Chronic sulfonylurea treatment and hyperglycemia aggravate disproportionately elevated plasma proinsulin levels in patients with type 2 diabetes.
    Inoguchi T; Umeda F; Kakimoto M; Sako Y; Ishii H; Noda K; Kunisaki M; Imamura M; Yu HY; Etoh T; Yoshikawa H; Aoki T; Hashimoto T; Nawata H
    Endocr J; 2000 Dec; 47(6):763-70. PubMed ID: 11228051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea.
    Dworacka M; Abramczyk M; Winiarska H; Kuczynski S; Borowska M; Szczawinska K
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):14-21. PubMed ID: 16425966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
    Ohkura T; Inoue K; Fujioka Y; Nakanishi R; Shiochi H; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Ohkura H; Kato M; Yamamoto K; Taniguchi S
    BMC Res Notes; 2013 Nov; 6():453. PubMed ID: 24215809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
    Prigeon RL; Jacobson RK; Porte D; Kahn SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
    J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus.
    Pfützner A; Lorra B; Abdollahnia MR; Kann PH; Mathieu D; Pehnert C; Oligschleger C; Kaiser M; Forst T
    Diabetes Technol Ther; 2006 Jun; 8(3):375-84. PubMed ID: 16800759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
    Wegner M; Winiarska H; Bobkiewicz-Kozłowska T; Dworacka M
    Cytokine; 2008 Jun; 42(3):312-6. PubMed ID: 18397831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated ratio of summed serum proinsulin to insulin response after oral glucose load in type 2 diabetes decreases following sulfonylurea treatment.
    Kumakura S; Iwamoto Y; Kuzuya T; Shiraishi I; Matsuda A; Saito T
    Diabetes Res Clin Pract; 1995 Aug; 29(2):107-12. PubMed ID: 8591697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma proinsulin in recently diagnosed type 2 diabetes mellitus.
    Schmidli RS; Hagan C; Scott RS; Livesey J; Forbes LV
    Diabetes Res Clin Pract; 1993 May; 20(2):133-8. PubMed ID: 8375266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Røder ME; Porte D; Schwartz RS; Kahn SE
    J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
    Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes.
    Vauhkonen IK; Niskanen LK; Mykkänen L; Haffner SM; Uusitupa MI; Laakso M
    Eur J Endocrinol; 2000 Aug; 143(2):251-60. PubMed ID: 10913945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-masked placebo-controlled trial assessing effects of various doses of BTS 67,582, a novel insulinotropic agent, on fasting hyperglycemia in NIDDM patients.
    Skillman CA; Raskin P
    Diabetes Care; 1997 Apr; 20(4):591-6. PubMed ID: 9096985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportional proinsulin responses in first-degree relatives of patients with type 2 diabetes mellitus.
    Røder ME; Eriksson J; Hartling SG; Groop L; Binder C
    Acta Diabetol; 1993; 30(3):132-7. PubMed ID: 8111072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
    Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
    Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subgroup analysis of proinsulin and insulin levels reveals novel correlations to metabolic indicators of type 2 diabetes.
    Li T; Quan H; Zhang H; Lin L; Lin L; Ou Q; Chen K
    Aging (Albany NY); 2020 Jun; 12(11):10715-10735. PubMed ID: 32532930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
    Van Dalem A; Demeester S; Balti EV; Keymeulen B; Gillard P; Lapauw B; De Block C; Abrams P; Weber E; Vermeulen I; De Pauw P; Pipeleers D; Weets I; Gorus FK;
    PLoS One; 2016; 11(12):e0166702. PubMed ID: 27907006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive association between the proinsulin-to-C-peptide ratio and prolonged hyperglycemic time in type 2 diabetes.
    Miya A; Nakamura A; Nomoto H; Kameda H; Atsumi T
    Endocr J; 2024 Apr; 71(4):403-408. PubMed ID: 38403638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.